Avenue rises after $33M listing

Avenue Therapeutics Inc. (NASDAQ:ATXI) gained $2.25 (38%) to $8.25 in its first day of trading Tuesday afternoon after it raised $33 million through the sale of 5.5 million shares at $6 in an IPO underwritten by Oppenheimer and the National Securities Corp. subsidiary of National Holdings Inc. (NASDAQ:NHLD). The offering valued Avenue at $53 million.

Avenue said last week it hoped to sell 5 million shares at $5-$7. At the $6 midpoint, it would have raised $30 million and been valued at $50 million...